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Abstract
Background: Signaling by extracellular adenosine 59-triphosphase (eATP) is very common for cell-to-cell communication in
many basic patho-physiological development processes. Rapid release of ATP into the extracellular environment from
distressed or injured eukaryotic cells due to pathogens or other etiological factors can serve as a ‘‘danger signal’’, activating
host innate immunity. However, little is known about how or whether pathogenic bacteria respond to this ‘‘danger signal’’.
Methods and Principal Findings: Here we report that extracellular dATP/ATP can stimulate bacterial adhesion and biofilm
formation via increased cell lysis and extracellular DNA (eDNA) release. We demonstrate that extracellular dATP/ATP also
stimulates bacterial adherence in vitro to human bronchial epithelial cells.
Conclusions and Significance: These data suggest that bacteria may sense extracellular dATP/ATP as a signal of ‘‘danger’’
and form biofilms to protect them from host innate immunity. This study reveals a very important and unrecognized
phenomenon that both bacteria and host cells could respond to a common important signal molecule in a race to adapt to
the presence of one another. We propose that extracellular dATP/ATP functions as an ‘‘inter-domain’’ warning signal that
serves to induce protective measures in both Bacterial and Eukaryotic cells.
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Introduction
Signaling by extracellular adenosine 59-triphosphase (eATP) plays
an important role in diverse patho-physiological processes and is
used ubiquitously amongst eukaryotes as an intercellular signal [1].
Recent work demonstrated that eATP acts as a signal molecule to
activate host inflammatory and immune response [2,3,4]. Pathogens
and other etiological factors can cause distress or injury of host cells
and stressed or injured cells release ATP via lytic or non-lytic
pathways.A rapid increase ofATPconcentration inthe extracellular
space acts as an early and sensitive sign of cellular stress (‘‘danger
signal’’) and alerts the immune system of an impending danger due
to exogenous and endogenous causes [5,6] to activate the quick
inflammatory response to clear invading pathogens. However, little
is known about whether and/or how bacterial pathogens can sense
and respond to the same ‘‘danger signal’’ (eATP) to avoid being
removed by the host innate immune response.
Biofilm formation is one of the mechanisms bacteria use to
survive in adverse environments [7,8,9,10]. Biofilm is an accumu-
lation of bacterial cells encapsulated in an extracellular polymer
matrix that adheres to surfaces and formation of biofilms can be
induced in response to stress conditions including sublethal
concentrations of aminoglycoside antibiotics [11], osmotic stress
[12], high metal concentration, extreme pH and temperature, the
addition of xenobiotics, antibiotics, and oxygen [13]. The matrix is
composed of extracellular polymeric substances (EPSs) which
include polysaccharides, proteins, nucleic acids and amphiphilic
polymers [14,15], which are secreted by microorganisms into their
environment [16]. The EPS is involved in the establishment of
stable arrangements of microorganisms in biofilms [17] and protect
embedded bacteria from attach of antimicrobials and human
immune system [7,8,9]. However, little is known about what factors
in eukaryotic host that affect bacterial biofilm formation or
dispersal. Here we report that extracellular dATP/ATP can
stimulate bacterial adhesion and biofilm formation via increased
cell lysis and extracellular DNA (eDNA) release, which could be one
of the mechanisms that bacteria employ to protect them from host
innate immunity. We hypothesize that extracellular dATP/ATP
functions as an ‘‘inter-domain’’ warning signal that serves to induce
protective measures in both Bacterial and Eukaryotic cells.
Results
dATP/ATP stimulates bacterial biofilm formation
We first tested the effect of dATP/ATP on Escherichia coli biofilm
formation and found that the addition of dATP or ATP (400 mM)
in culture media, which is in the range of physiological eATP
concentration, can stimulate E. coli initial attachment and biofilm
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13355formation on the glass surface (Figures 1 and 2). Dense, thick and
carpet-like biofilm was formed by E. coli cells in the presence of
dATP (Figures 1. B) compared to loosen carpet-like biofilm
without dATP treatment (Figures 1. A). Attached biofilm biomass
increased by about 50% (Figure 2) with dATP treatment. dATP
treatment did not have observable effect on E. coli growth in
suspended cultures (Figure 3. A). Treatment with apyrase
(200 mU/ml), an enzyme that catalyses the hydrolysis of ATP to
yield AMP and inorganic phosphate [18], partially arrested E. coli
biofilm development (Figures 1. D). Only dispersed microcolonies
were observed on the surface and there was about 40% reduction
of biofilm biomass compared to without the apyrase treatment
(Figure 2), suggesting that eATP is required for biofilm formation.
In addition, E. coli developed about 50% less biofilm when treated
with dATP (400 mM) and apyrase (200 mU/ml) together
(Figure 2), demonstrating it is dATP that stimulates E. coli biofilm
development. We also tested the effects of other three nucleotides
(dCTP, dGTP and dTTP) on E. coli biofilm formation and found
that dGTP has a similar effect with less extent and no effects from
dCTP and dTTP treatment was found (data not shown). dATP
can also stimulate biofilm formation of several other pathogenic
bacterial strains including Acinetobacter baumannii, Stenotrophomonas
maltophilia and Staphylococcus aureus (Figure 3. B), without observed
impact on their growth (Figure 3. A), although these strains have
different biofilm formation capacity. This data suggests that the
stimulus effect of dATP on bacterial biofilm formation might be
common among different bacterial strains.
Extracellular DNA is involved in the stimulus effect of
dATP/ATP
We further studied how bacteria cells respond to eATP with a focus
on the link with extracellular DNA (eDNA). eDNA is one of the major
components of EPS [19,20] that bacteria release as part of the biofilm
matrix and is critical for biofilm development, e.g., facilitates initial
bacterial attachment to abiotic or biotic surfaces and maintain the
structure of mature biofilms [20,21,22,23,24,25,26,27]. We first tested
t h er o l eo fe D N Ai nE. coli biofilm development. DNase treatment
arrested E. coli biofilm formation (Figure 2), and only dispersed
microcolonies attached on the glass surface can be observed (Figure 1.
C). Attached E. coli biofilm biomass was reduced about 50% with
DNase treatment (Figure 2). E. coli biofilm formation was completely
arrested by the treatment with dATP together with DNase (Figure 2),
Figiure 1. Confocal laser scanning micrographs of biofilms developed by E. coli K-12 in 10% LB broth with different reagents. A,
control, without any additional reagents; B, with 400 mM of dATP;, C, with 40 U/ml of DNase I; and D, with 200 mU/ml of Apyrase. Biofilms were
examined after 16 hrs incubation after inoculation at 30uC in a 96-well microtiter plate. Bacterial cells were stained with Bacterial LIVE/DEAD staining
dyes and viable cells shown green and dead or membrane damaged cells shown red in the images.
doi:10.1371/journal.pone.0013355.g001
Figure 2. Quantification of biofilms developed by E. coli K-12 in
10% LB supplemented with different reagents: no addition of
any reagents (control); DNase I (40 U/ml); Apyrase (200 mU/ml);
dATP (400 mM); dATP (400 mM) and DNase I (40 U/ml); or dATP
(400 mM) and Apyrase (200 mU/ml). Biofilms were examined after
16 hrs incubation after inoculation at 30uC in a 96-well microtiter plate.
Crystal violet staining assay was used to determine biofilm biomass.
doi:10.1371/journal.pone.0013355.g002
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involves eDNA. Thus we tested whether dATP treatment could
induce eDNA release and found that dATP treatment increased about
48% of eDNA release in E. coli planktonic cells or about 200% of
eDNA release in the biofilm matrix (Figure 4. B), without impacting E.
coli growth in suspended cultures (Figure 4. A). Moreover, the
percentage of membrane-damaged cells attached on the glass surface
after incubation for two hours increased more than 2-fold in the
presence of dATP treatment (9.58% with dATP treatment vs. 3.99%
without dATP treatment; p value ,0.01) and total attached cells
increased from 3.02610
5 cells/cm
2 to 7.97610
5 cells/cm
2 (Figure 5).
These data suggest that exogenous dATP can induce cell lysis and
eDNA release, leading to increased bacterial attachment and biofilm
formation on abiotic surfaces.
dATP stimulates bacterial adherence to human epithelial
cells
Interestingly, in early studies of animal models of Pseudomonas
infection, few bacteria were found to be adherent unless the
respiratory epithelium was injured by acid or viral infection [28].
Wound or cell damage in epithelial cells can induce rapid release of
ATP [29]; therefore, we further tested whether eATP is involved in
bacterial adherence to epithelial cells. We used an in vitro cell culture
model of human bronchial epithelial NCI-H292 cells and A.
baumannii was chosen for this test. A. baumannii is an emerging
bacterial pathogen and is responsible for the majority of nosocomial
pulmonary infections [30,31]. We found that supplementing the
media with 400 mM of dATP increased A. baumannii adherence
about 100-fold one hour after incubation (1080 bacterial cells/100
tissue cells with dATP treatment vs. 8 bacterial cells/100 tissue cells
without dATP treatment), by counting adhered bacterial cells on the
monolayer of the bronchial epithelial cells, and promoted bacterial
aggregate formation on human bronchial epithelial cells (Figure 6).
The data was confirmed by counting viable A. baumannii cells
adhered to the monolayer of human bronchial epithelial cells in the
petri dish (8.79610
5 CFU/cm
2 (66.63610
4 CFU/cm
2)v s .
1.6610
4 CFU/cm
2 (61.2610
3 CFU/cm
2) without dATP treat-
ment). The similar level of increased bacterial adherence was
observed when a small portion of human cells were physically
damaged (Figure6). Rapid increaseof ATP intothe media waslikely
occurred due to this damage. Increased bacterial adherence either
due to exogenous added dATP or cell damage was completely
arrested by the apyrase (200 mU/ml) treatment (Figure 6). These
data clearly demonstrated that bacteria respond very quickly to
exogenous dATP or ATP released from damaged cells and increase
adherence to human epithelial cells.
Figure 3. Growth and biofilm formation of different strains in the absence (control) or the presence of dATP (dATP200,
200 mM of dATP; dATP400, 400 mMo fd A T P ) .1% overnight culture were inoculated in 100 ml of 10% LB broth in wells of 96-well
microtiter plate with different concentration of dATP, 10% LB without dATP was set as control. A, growth OD was measured by reading
absorbance at 600 nmafter 16 hours incubation at 30uC. B, biofilm biomass was recorded by reading absorbance at 600 nm after crystal violet
staining. Statistical analysis of three independent experiments showed significant increase of biofilm formation by all strains in the presence
of dATP.
doi:10.1371/journal.pone.0013355.g003
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Bacteria and their eukaryotic hosts have coexisted for millions of
years and bacteria could be beneficial, neutral or detrimental to
their hosts. Eukaryotic hosts and bacteria developed different
mechanisms to maintain a fine balance and communicate with
each other through different signals, e.g. hormonal signals [32].
The concept of using eATP as an extracellular messenger was first
proposed over 30 years ago [1] and it was recently found it can act
as a ‘‘danger signal’’ to alert and activate host immune system to
prevent bacterial infections [2,3,4]. In this study, we tested
whether bacteria could take advantage of this signal molecule
released either from the host and/or themselves for their benefits
when interact with their eukaryotic host.
We first tested the response of bacteria to exogenous added
dATP/ATP. It was found that dATP can stimulate biofilm
formation by bacterial strains tested (Figures 1, 2 and 3). Four
bacterial species including Gram-negative bacteria E. coli, A.
baumannii, S. maltophilia and Gram-positive bacterium S. aureus have
been tested with more detailed studies on E. coli and A. baumannii.
E. coli is a well studied model organism and available knowledge
and database about gene regulations in this bacterium will be
useful for further studies on extracellular ATP signaling. A.
baumannii is a notorious nosocomial pathogen that causes a range
Figure 4. Growth of E.coli K-12 in suspensions and biofilms and eDNA released in suspended cultures and biofilm matrix in 10% LB
supplemented with or without dATP (400 mM). A, growth of E.coli K-12 in suspensions and biofilms; B, eDNA in cultures and biofilm matrix.
eDNA was extracted using the method we developed (see the Materials and Methods section) and quantified using the PicoGreen dsDNA
Quantitation Kit (Molecular Probes, Invitrogen). P values from statistical analysis of three independent experiments were shown in the graph. Student
T-test was used for statistic analysis.
doi:10.1371/journal.pone.0013355.g004
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meningitis, endocarditis, wound infections and bacteraemia,
especially in intensive care unit patients [33,34]. It becomes a
serious concern of hospital acquired infection because of the
emergence of multidrug-resistant strains of this specie and some of
them are pan-resistant to antimicrobial agents. These four
bacterial species respond similarly to exogenous dATP/ATP
treatment on biofilm formation led us to propose that the stimulus
effect of dATP/ATP on biofilm formation could be common
among other bacterial species; furthermore, more tests on much
broader representative species would strengthen this hypothesis.
Exogenously added dATP increased biofilm formation and this
effect was removed by the apyrase treatment (Figures 1 and 2).
Apyrase is an enzyme that catalyses the hydrolysis of ATP to yield
AMP and inorganic phosphate [18]. Apyrase treatment not only
eliminated the effect of exogenously added dATP but also further
arrested biofilm formation to a similar level of DNase treatment. It
has been demonstrated that extracellular DNA is a major
component of biofilm matrix and required for biofilm formation
by different bacterial strains, which was initially tested in a study
which found that DNase treatment arrested biofilm formation
[21]. The similar effect caused by the apyrase treatment as the
DNase treatment suggest that extracellular ATP might be also
required for biofilm formation, although it is not clear about
mechanisms of the role of extracellular ATP in biofilm formation.
Further tests in this study found a link between the effect of
dATP/ATP treatment and extracellular DNA on biofilm
formation. It was found that dATP/ATP treatment induced cell
lysis and eDNA release both in suspended cultures and biofilms
(Figure 4), which suggest that extracellular DNA probably is
involved in the stimulus effect of dATP/ATP on biofilm
formation. It is not clear, though, about how bacterial cells sense
extracellular dATP/ATP and how dATP/ATP causes cell lysis
and DNA release. In eukaryotic cells, there are two type of
purinoreceptors (P2X and P2Y) which can be activated by ATP
[35]. Although we haven’t found homologous receptors in E. coli
using the BLAST search(data not shown), it is not likely due to
toxic effects of ATP on bacterial cells for cell lysis and DNA release
since exogenously added ATP doesn’t affect E. coli growth. Thus
we believe that E. coli cells may sense extracellular ATP and
Figure 5. Quantification and fluorescent micrographs of cell attachment and cell lysis on glass surfaces of the E. coli strain. E. coli (1–
1.5610
6 CFU/mL) was incubated in a petri dish with glass coverslips submerged in 10% LB supplemented with or without dATP (400 mM) at 30uC
with gentle shaking for 2 hours. Coverslips were stained with Bacterial Live/Dead staining dyes before being observed under an epi-fluorescent
microscope. A, number of bacterial cells attached to the glass surfaces; B, percentage of dead or membrane damaged cells; C, Representative
micrographs shown attached live cells (green) and dead cells (red).
doi:10.1371/journal.pone.0013355.g005
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process might be similar to eukaryotic programmed cell death.
Other cellular processes in addition to cell lysis and eDNA release
may also be involved in the stimulus effect. Further studies are
warranted to elucidate molecular mechanisms of this effect of ATP
on biofilm formation.
Recent study found that extracellular dATP/ATP can act a
‘‘danger signal’’ to alert and activate host immune system to
prevent bacterial infection, which led us to use an in vitro cell
culture test to study whether extracellular dATP/ATP could
promote bacterial adherence to eukaryotic cells. We found that
exogenously added dATP or ATP from damaged cell increased
bacteria adherence and this effect was attenuated by apyrase
treatment (Figure 6). The data suggest bacterial cells can adhere to
eukaryotic cells in response to extracellular dATP/ATP. In this
experiment, it was also found that dATP treatment changed the
morphology of human bronchial epithelial cells (Figure 6. C),
suggesting that host cells also respond to exogenously added
dATP. This change may also contribute to increased bacterial
adherence but clearly could not the sole factor. This study and
previous studies in literatures led us to propose that dATP/ATP
may act as an ‘‘inter-domain’’ signal molecule that regulates the
interaction between Eukaryotic and Bacterial cells. Further in vivo
animal model studies, e.g. lung or wound infection model, to test
ATP treatment and/or apyrase treatment on the induction of
proinfammatory cytokins in host and bacterial colonization and
infection would provide more in depth understanding of this
‘‘inter-domain’’ signaling.
In conclusion, we found bacteria may sense extracellular
dATP/ATP as a ‘‘danger signal’’ and initiate cell lysis and eDNA
release resulting in increased bacterial adherence and biofilm
formation for the purpose of protecting them from the activated
host innate immunity. This study reveals a potentially very
important and unrecognized phenomenon that both bacteria and
host cells can respond to a same important signal molecule in a
race to adapt to the presence of one another. Further study of this
phenomenon will lead to more comprehensive understanding of
bacteria-host interactions and bacterial pathogenesis and will likely
Figure 6. Quantification and light micrographs demonstrating the simulative effect of dATP on adherence of A. baumannii to human
bronchial epithelial NCI-H292 cells. A, Number of A. baumannii cells adhered to the monolayer of 100 human bronchial epithelial NCI-H292 cells
after 1 hour incubation at 37uC with 5% (v/v) CO2 in the RPMI 1640 medium with different treatments: Control (no treatment); dATP (medium
supplemented 400 mM of dATP; Apyrase (medium supplemented with 200 mU/ml of Apyrase; Damage (around 5% of a monolayer of the epithelial
cells was damaged); and a combination of two treatments. Three independent experiments were performed for each treatment and standard
deviations of three treatments were included. B, Representative light micrograph of A. baumannii cells adhered to the epithelial cells after incubation
in the RPMI 1640 medium without supplementing dATP;and, C, with supplementing dATP. (Objective 606).
doi:10.1371/journal.pone.0013355.g005
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infections and to treat related human diseases.
Materials and Methods
Bacterial strains, media and enzymes
E.coli K-12 BW25113, Acinetobacter baumannii ATCC 17978,
Stenotrophomonas maltophilia, and Staphylococcus aureus ATCC 25923
were grown on rich medium (Luria-Bertani; LB) overnight at 37uC
with shaking at 250 rpm. Biofilm were grown at 30uC in 10% of
LB medium in the wells of 96-well microtitre plates. DNase I and
Apyrase were obtained from New England Biolabs. dATP and
ATP were obtained from Promega (Promega Company, Madison,
WI). All other chemicals, unless otherwise specified, were reagent
grade or higher (Sigma-Aldrich. St. Louis, MO).
Biofilm growth and harvesting
Development of biofilms was performed in 96-well microtiter
plates following the method as described previously [36].
Quantification of biofilm biomass was obtained by using the
method according to O’Toole et al. [37]. 1% of overnight culture
was inoculated into the wells of 96-well microplate containing
100 ml of 10% LB media supplemented with different concentra-
tion of dATP/ATP, Apyrase or DNase accordingly. After 16 h of
incubation at 30uC, 15 ml of a 1% solution of crystal violet (CV)
was added to each well to stain the cells for 15 min. Then, the
wells were rinsed thoroughly with PBS buffer three times. Biofilm
formation was quantified by the addition of 100 ml of 95% ethanol
to each CV-stained microplate well, and the absorbance was
determined with a plate reader at 600 nm (Synergy HT, Bio-Tek.
Winooski, VT).
Image acquisition and analysis
All microscopic observations and image acquisitions were
performed with Olympus IX71 equipped with detectors and filter
sets for monitoring of SYTO-9 and propidium iodide (PI). Images
were obtained using a 606objective. Biofilm samples were stained
with LIVE/DEAD BacLight Bacterial Viability Kits (cat. L7007,
Invitrogen) following the instructions in the manual. Three
dimensional images were performed with an Olympus Fluo-
view
TM FV1000 confocal microscope (Olympus, Markham,
Ontario) with Melles Griot Laser supply and detectors and filter
sets for monitoring SYTO 9 and PI fluorescence. Images were
obtained using a 606 objective. Simulated 3D images were
reconstructed using the Amira software package (Amira, San
Diego, CA).
Extraction and quantification of extracellular DNA
Biofilms were developed as mentioned above for 16 hours and
biofilm cells were resuspended with 0.9% NaCl solution,
homogenized for 1 min and were ready for eDNA extraction.
Planktonic cells were incubated at 30uC for 8 hours with a 1% of
inoculation and cells were washed with fresh 10% of LB broth
three times before resuspended in the same volume of 10% of LB
broth or 10% LB broth supplemented with 400 mM of dATP. The
cells solutions were then incubated at 30uC for another 2 hour and
were ready for eDNA extraction. Biofilm cells suspension and
planktonic cultures were treated as previously reported [38] for
DNA extraction. Briefly, cell solution was treated with Dispersin B
(20 mg/ml) at 37uC for 30 min followed by treatment of proteinase
K( 5mg/ml) for another 30 min at 37uC. Treated cell solution was
filtered through a 0.2 mm syringe filter (PES, Water & Process
Technologies), elute was used to extract the extracellular DNA by
using ethanol precipitation. DNA was dissolved in 50 ml of sterile
MilliQ water and the concentration of DNA was measured by
using the PicoGreen dsDNA Quantitation Kit (Molecular Probes,
Invitrogen).
Cell Attachment Assay
1% of overnight E. coli culture was inoculated in 20 ml of 10%
LB broth in petri dish with glass coverslips in absent or present of
dATP. Petri dish plate was incubated at 30uC with shaking at
80 rpm. After 2 hours, coverslips were taken out, gently washed
with PBS buffer three times and stained with LIVE/DEAD
BacLight Bacterial Viability Kits for cell number counting. Three
coverslips were observed for each test and five randomly chosen
images were taken from each coverslip. Number of attached cells
was counted from each image and percentage of membrane
damaged cells (red cells) was calculated. Student T-test was used
for statistic analysis.
In vitro bacterial adherence assay
Bacterial adherence assay was performed following a method
described previously [39]. Human bronchial epithelial cell line
NCI-H292 (ATCC CRL-1848; American Tissue Culture Collec-
tion, Rockville, MD, USA) were cultured in a petri dish at 37uCi n
RPMI 1640 medium (Gibco BRL, Grand Island, NY, USA),
supplemented with 25 mM HEPES, 2 mM L-glutamine, penicillin
G 100,000 U/L, streptomycin 50 mg/L and 10% (v/v) of fetal
bovine serum (Gibco BRL), in a humidified atmosphere
containing 5% (v/v) of CO2.
Two ml of fresh NCI-H292 (1610
5 cells/ml) cell solution were
transferred to each well of a 12-well plate, which contained a 13-
mm-diameter plastic coverslip (Thermanox, Nunc, Rochester,
NY, USA) in each well. The cells were incubated at 37uC for
about 3 days until cells covered about 90% of coverslip and were
then washed with phosphate buffered saline (PBS) three times.
Overnight culture of Acinetobacter baumannii ATCC 17978 were
washed and mixed with reagents (400 mM of dATP, or 200 mU/
ml of apyrase) in PBS if necessary. Each cell monolayer was
infected with 1 mL of bacterial suspension (1610
8 CFU/mL) and
incubated for 60 min at 37uCi naC O 2 5% v/v atmosphere. For
damaged cell assays, NCI-H292 cells (around 5%) in the central
area of plastic coverslips were damaged by tip of a knife before the
infection performed. After infected by Acinetobacter baumannii
ATCC 17978, plastic coverslips were washed with PBS buffer
three times to remove non-adherent bacteria. Some of coverslips
were mixed with 3 ml of PBS buffer and homogenized for 30 sec.
Mixtures were diluted 10-fold serially for plate counting. Some
coverslips were fixed in 100% of methanol for 20 min before being
stained in a Giemsa staining solution for 30 min at room
temperature. The coverslips were air-dried, mounted and
observed under a light microscope with a 660 objective len.
The number of bacteria adhering to 100 cells was determined.
Three independent experiments were performed for each
treatment.
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